SpyGlass Pharma, Inc.
SGP- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001778922
No open-market purchases or sales by SpyGlass Pharma, Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $581.1M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in SpyGlass Pharma, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +35 vs. Q4 2025
- Shares held
- 25.4M
- +25.4M vs. Q4 2025
- Total value
- $655.4M
- +$655.4M vs. Q4 2025
- New holders
- 35
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 52 | $581.1M |
| Q1 2026 | 35 | $655.4M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding SpyGlass Pharma, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,021,117 | $207.8M | 2.20% | +8,021,117 | New |
| NEA Management Company, LLC | 7,392,301 | $191.5M | 10.89% | +7,392,301 | New |
| Sands Capital Ventures, LLC | 2,500,012 | $64.8M | 15.38% | +2,500,012 | New |
| Samsara BioCapital, LLC | 2,109,953 | $54.7M | 5.31% | +2,109,953 | New |
| Price T Rowe Associates Inc | 704,440 | $18.3M | 0.00% | +704,440 | New |
| Vestal Point Capital, LP | 666,760 | $17.3M | 0.48% | +666,760 | New |
| Deerfield Management Company, L.P. (Series C) | 550,000 | $14.3M | 0.17% | +550,000 | New |
| JPMorgan Chase & Co | 577,109 | $13.5M | 0.00% | +577,109 | New |
| Millennium Management LLC | 468,794 | $12.1M | 0.01% | +468,794 | New |
| Vanguard Capital Management LLC | 434,813 | $11.3M | 0.00% | +434,813 | New |
| First Light Asset Management, LLC | 375,000 | $9.72M | 0.87% | +375,000 | New |
| Franklin Resources Inc | 300,000 | $7.77M | 0.00% | +300,000 | New |
| Affinity Asset Advisors, LLC | 250,000 | $6.48M | 0.38% | +250,000 | New |
| Standard Life Aberdeen plc | 220,454 | $5.71M | 0.01% | +220,454 | New |
| BlackRock, Inc. | 144,739 | $3.75M | 0.00% | +144,739 | New |
| Geode Capital Management, LLC | 126,540 | $3.28M | 0.00% | +126,540 | New |
| Monashee Investment Management LLC | 95,000 | $2.46M | 1.34% | +95,000 | New |
| Vanguard Fiduciary Trust Co | 59,782 | $1.55M | 0.00% | +59,782 | New |
| Charles Schwab Investment Management Inc | 59,610 | $1.54M | 0.00% | +59,610 | New |
| Alyeska Investment Group, L.P. | 57,000 | $1.48M | 0.00% | +57,000 | New |
| TD Asset Management Inc | 47,580 | $1.23M | 0.00% | +47,580 | New |
| Ameriprise Financial Inc | 44,477 | $1.15M | 0.00% | +44,477 | New |
| Marshall Wace, LLP | 29,348 | $760.4K | 0.00% | +29,348 | New |
| Bank of America Corp | 28,020 | $726.0K | 0.00% | +28,020 | New |
| Northern Trust Corp | 20,862 | $540.5K | 0.00% | +20,862 | New |
| Goldman Sachs Group Inc | 19,283 | $499.6K | 0.00% | +19,283 | New |
| State Street Corp | 17,250 | $446.9K | 0.00% | +17,250 | New |
| Manufacturers Life Insurance Company, The | 11,870 | $307.6K | 0.00% | +11,870 | New |
| Squarepoint Ops LLC | 7,811 | $202.4K | 0.00% | +7,811 | New |
| Vanguard Global Advisers, LLC | 4,927 | $127.7K | 0.00% | +4,927 | New |
| Morgan Stanley | 4,179 | $108.3K | 0.00% | +4,179 | New |
| Vanguard Portfolio Management LLC | 3,680 | $95.3K | 0.00% | +3,680 | New |
| UBS Group AG | 455 | $11.8K | 0.00% | +455 | New |
| Barclays PLC | 140 | $3.63K | 0.00% | +140 | New |
| Royal Bank of Canada | 85 | $2.00K | 0.00% | +85 | New |